Literature DB >> 9665064

Cell cycle progression: new therapeutic target for vascular proliferative disease.

R C Braun-Dullaeus1, M J Mann, V J Dzau.   

Abstract

Entry into and progression of vascular cells through the cell cycle is considered a key event in vascular proliferative diseases. Multiple growth factors and cytokines have been found to regulate vascular cell proliferation. However, the machinery regulating cell cycle represents the "final common pathway" of these signaling cascades and thus provides an attractive therapeutic target for the prevention of vascular proliferative diseases. This review focuses on the current understanding of the regulation of the cell cycle machinery especially as it relates to vascular cell biology and the feasibility of targeting cell cycle for the prevention of restenosis after balloon angioplasty and bypass vein graft disease.

Entities:  

Mesh:

Year:  1998        PMID: 9665064     DOI: 10.1161/01.cir.98.1.82

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  68 in total

1.  Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.

Authors:  Federica Barchiesi; Eliana Lucchinetti; Michael Zaugg; Omolara O Ogunshola; Matthew Wright; Markus Meyer; Marinella Rosselli; Sara Schaufelberger; Delbert G Gillespie; Edwin K Jackson; Raghvendra K Dubey
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

2.  Sulindac inhibits neointimal formation after arterial injury in wild-type and apolipoprotein E-deficient mice.

Authors:  E D Reis; M Roque; H Dansky; J T Fallon; J J Badimon; C Cordon-Cardo; S J Shiff; E A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

3.  Regulation of vascular smooth muscle cell growth: targeting the final common pathway.

Authors:  Angela M Taylor; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-01       Impact factor: 8.311

4.  Regulation of vascular smooth muscle cell proliferation by nuclear orphan receptor Nur77.

Authors:  Liyue Wang; Fan Gong; Xiaoyan Dong; Wei Zhou; Qiutang Zeng
Journal:  Mol Cell Biochem       Date:  2010-04-22       Impact factor: 3.396

5.  Human tissue kallikrein 1 gene delivery inhibits PDGF-BB-induced vascular smooth muscle cells proliferation and upregulates the expressions of p27Kip1 and p2lCip1.

Authors:  Hui-Zhen Yu; Liang-di Xie; Peng-li Zhu; Chang-sheng Xu; Hua-jun Wang
Journal:  Mol Cell Biochem       Date:  2011-09-30       Impact factor: 3.396

6.  Valsartan inhibits angiotensin II-induced proliferation of vascular smooth muscle cells via regulating the expression of mitofusin 2.

Authors:  Hua Liao; Junrong Gong; Wenjuan Zhang; Xiaomei Guo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-01-27

Review 7.  Pleiotropic effects of statins.

Authors:  James K Liao; Ulrich Laufs
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

Review 8.  Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol.

Authors:  James K Liao
Journal:  Am J Cardiol       Date:  2005-09-05       Impact factor: 2.778

Review 9.  The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.

Authors:  Thierry Charron; Nafiseh Nili; Bradley H Strauss
Journal:  Can J Cardiol       Date:  2006-02       Impact factor: 5.223

10.  Silencing heat shock protein 27 (HSP27) inhibits the proliferation and migration of vascular smooth muscle cells in vitro.

Authors:  Jie Huang; Liang-di Xie; Li Luo; Su-Li Zheng; Hua-Jun Wang; Chang-Sheng Xu
Journal:  Mol Cell Biochem       Date:  2014-01-28       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.